title: Psoriasis and psoriatic arthritis treatment.
abstract: Over the past several years, an increased understanding of the pathophysiology of psoriasis and psoriatic arthritis (PsA) has led to the development of several new biologic therapies. Appropriate treatment selection and timing may slow, and even halt, the progression of psoriasis and PsA; as a result, it can decrease the economic burden. As treatment options vary based on individual disease characteristics and patient preferences, reviewing the patient's complete clinical picture is imperative. An updated treatment algorithm, based on patients' most severe disease domain, is now available to guide the selection of optimal therapy. Special care should be given to patients with both psoriasis and PsA who experience multiple disease domains, a heavy symptom burden, and an increased risk of comorbidities.
authors.affiliation: amderm@gmail.com.
authors.forename: Alan
authors.initials: A
authors.lastname: Menter
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000523:psychology / Q000628:therapy; D001685:Biological Factors / Q000627:therapeutic use*; D019468:Disease Management; D005260:Female; D006801:Humans; D008297:Male; D010789:Phototherapy / Q000379:methods*; D011565:Psoriasis / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D011788:Quality of Life; D012008:Recurrence; D018570:Risk Assessment; D012720:Severity of Illness Index; D018434:Sickness Impact Profile; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D001685:Biological Factors